0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Boron-containing Compounds Drug Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-2A17546
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Boron containing Compounds Drug Market Research Report 2024
BUY CHAPTERS

Global Boron-containing Compounds Drug Market Research Report 2024

Code: QYRE-Auto-2A17546
Report
June 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Boron-containing Compounds Drug Market

The global Boron-containing Compounds Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Boron-containing Compounds Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Boron-containing Compounds Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Boron-containing Compounds Drug include Takeda Pharmaceutical, Janssen Pharmaceuticals, Pfizer, Hovione FarmaCiencia, Melinta Therapeutics, DC PHARMA, Gao Jin Biology, Neuboron, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Boron-containing Compounds Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Boron-containing Compounds Drug.
The Boron-containing Compounds Drug market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Boron-containing Compounds Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Boron-containing Compounds Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Boron-containing Compounds Drug Market Report

Report Metric Details
Report Name Boron-containing Compounds Drug Market
Segment by Type
  • Bortezomib
  • Tavaborole
  • Crisaborole
  • Vaborbactam-Meropenem
  • Ixazomib
  • Others
Segment by Application
  • Multiple Myeloma
  • Toenail Fungal Infection
  • Atopic Dermatitis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceutical, Janssen Pharmaceuticals, Pfizer, Hovione FarmaCiencia, Melinta Therapeutics, DC PHARMA, Gao Jin Biology, Neuboron
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Boron-containing Compounds Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Boron-containing Compounds Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Boron-containing Compounds Drug Market report?

Ans: The main players in the Boron-containing Compounds Drug Market are Takeda Pharmaceutical, Janssen Pharmaceuticals, Pfizer, Hovione FarmaCiencia, Melinta Therapeutics, DC PHARMA, Gao Jin Biology, Neuboron

What are the Application segmentation covered in the Boron-containing Compounds Drug Market report?

Ans: The Applications covered in the Boron-containing Compounds Drug Market report are Multiple Myeloma, Toenail Fungal Infection, Atopic Dermatitis, Others

What are the Type segmentation covered in the Boron-containing Compounds Drug Market report?

Ans: The Types covered in the Boron-containing Compounds Drug Market report are Bortezomib, Tavaborole, Crisaborole, Vaborbactam-Meropenem, Ixazomib, Others

1 Boron-containing Compounds Drug Market Overview
1.1 Product Definition
1.2 Boron-containing Compounds Drug by Type
1.2.1 Global Boron-containing Compounds Drug Market Value Comparison by Type (2024-2030)
1.2.2 Bortezomib
1.2.3 Tavaborole
1.2.4 Crisaborole
1.2.5 Vaborbactam-Meropenem
1.2.6 Ixazomib
1.2.7 Others
1.3 Boron-containing Compounds Drug by Application
1.3.1 Global Boron-containing Compounds Drug Market Value by Application (2024-2030)
1.3.2 Multiple Myeloma
1.3.3 Toenail Fungal Infection
1.3.4 Atopic Dermatitis
1.3.5 Others
1.4 Global Boron-containing Compounds Drug Market Size Estimates and Forecasts
1.4.1 Global Boron-containing Compounds Drug Revenue 2019-2030
1.4.2 Global Boron-containing Compounds Drug Sales 2019-2030
1.4.3 Global Boron-containing Compounds Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Boron-containing Compounds Drug Market Competition by Manufacturers
2.1 Global Boron-containing Compounds Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Boron-containing Compounds Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Boron-containing Compounds Drug Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Boron-containing Compounds Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Boron-containing Compounds Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Boron-containing Compounds Drug, Product Type & Application
2.7 Global Key Manufacturers of Boron-containing Compounds Drug, Date of Enter into This Industry
2.8 Global Boron-containing Compounds Drug Market Competitive Situation and Trends
2.8.1 Global Boron-containing Compounds Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Boron-containing Compounds Drug Players Market Share by Revenue
2.8.3 Global Boron-containing Compounds Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Boron-containing Compounds Drug Market Scenario by Region
3.1 Global Boron-containing Compounds Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Boron-containing Compounds Drug Sales by Region: 2019-2030
3.2.1 Global Boron-containing Compounds Drug Sales by Region: 2019-2024
3.2.2 Global Boron-containing Compounds Drug Sales by Region: 2025-2030
3.3 Global Boron-containing Compounds Drug Revenue by Region: 2019-2030
3.3.1 Global Boron-containing Compounds Drug Revenue by Region: 2019-2024
3.3.2 Global Boron-containing Compounds Drug Revenue by Region: 2025-2030
3.4 North America Boron-containing Compounds Drug Market Facts & Figures by Country
3.4.1 North America Boron-containing Compounds Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Boron-containing Compounds Drug Sales by Country (2019-2030)
3.4.3 North America Boron-containing Compounds Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Boron-containing Compounds Drug Market Facts & Figures by Country
3.5.1 Europe Boron-containing Compounds Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Boron-containing Compounds Drug Sales by Country (2019-2030)
3.5.3 Europe Boron-containing Compounds Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Boron-containing Compounds Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Boron-containing Compounds Drug Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Boron-containing Compounds Drug Sales by Region (2019-2030)
3.6.3 Asia Pacific Boron-containing Compounds Drug Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Boron-containing Compounds Drug Market Facts & Figures by Country
3.7.1 Latin America Boron-containing Compounds Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Boron-containing Compounds Drug Sales by Country (2019-2030)
3.7.3 Latin America Boron-containing Compounds Drug Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Boron-containing Compounds Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Boron-containing Compounds Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Boron-containing Compounds Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Boron-containing Compounds Drug Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Boron-containing Compounds Drug Sales by Type (2019-2030)
4.1.1 Global Boron-containing Compounds Drug Sales by Type (2019-2024)
4.1.2 Global Boron-containing Compounds Drug Sales by Type (2025-2030)
4.1.3 Global Boron-containing Compounds Drug Sales Market Share by Type (2019-2030)
4.2 Global Boron-containing Compounds Drug Revenue by Type (2019-2030)
4.2.1 Global Boron-containing Compounds Drug Revenue by Type (2019-2024)
4.2.2 Global Boron-containing Compounds Drug Revenue by Type (2025-2030)
4.2.3 Global Boron-containing Compounds Drug Revenue Market Share by Type (2019-2030)
4.3 Global Boron-containing Compounds Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Boron-containing Compounds Drug Sales by Application (2019-2030)
5.1.1 Global Boron-containing Compounds Drug Sales by Application (2019-2024)
5.1.2 Global Boron-containing Compounds Drug Sales by Application (2025-2030)
5.1.3 Global Boron-containing Compounds Drug Sales Market Share by Application (2019-2030)
5.2 Global Boron-containing Compounds Drug Revenue by Application (2019-2030)
5.2.1 Global Boron-containing Compounds Drug Revenue by Application (2019-2024)
5.2.2 Global Boron-containing Compounds Drug Revenue by Application (2025-2030)
5.2.3 Global Boron-containing Compounds Drug Revenue Market Share by Application (2019-2030)
5.3 Global Boron-containing Compounds Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Company Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Boron-containing Compounds Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Pharmaceutical Boron-containing Compounds Drug Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Janssen Pharmaceuticals
6.2.1 Janssen Pharmaceuticals Company Information
6.2.2 Janssen Pharmaceuticals Description and Business Overview
6.2.3 Janssen Pharmaceuticals Boron-containing Compounds Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Janssen Pharmaceuticals Boron-containing Compounds Drug Product Portfolio
6.2.5 Janssen Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Boron-containing Compounds Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Boron-containing Compounds Drug Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Hovione FarmaCiencia
6.4.1 Hovione FarmaCiencia Company Information
6.4.2 Hovione FarmaCiencia Description and Business Overview
6.4.3 Hovione FarmaCiencia Boron-containing Compounds Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hovione FarmaCiencia Boron-containing Compounds Drug Product Portfolio
6.4.5 Hovione FarmaCiencia Recent Developments/Updates
6.5 Melinta Therapeutics
6.5.1 Melinta Therapeutics Company Information
6.5.2 Melinta Therapeutics Description and Business Overview
6.5.3 Melinta Therapeutics Boron-containing Compounds Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Melinta Therapeutics Boron-containing Compounds Drug Product Portfolio
6.5.5 Melinta Therapeutics Recent Developments/Updates
6.6 DC PHARMA
6.6.1 DC PHARMA Company Information
6.6.2 DC PHARMA Description and Business Overview
6.6.3 DC PHARMA Boron-containing Compounds Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 DC PHARMA Boron-containing Compounds Drug Product Portfolio
6.6.5 DC PHARMA Recent Developments/Updates
6.7 Gao Jin Biology
6.7.1 Gao Jin Biology Company Information
6.7.2 Gao Jin Biology Description and Business Overview
6.7.3 Gao Jin Biology Boron-containing Compounds Drug Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Gao Jin Biology Boron-containing Compounds Drug Product Portfolio
6.7.5 Gao Jin Biology Recent Developments/Updates
6.8 Neuboron
6.8.1 Neuboron Company Information
6.8.2 Neuboron Description and Business Overview
6.8.3 Neuboron Boron-containing Compounds Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Neuboron Boron-containing Compounds Drug Product Portfolio
6.8.5 Neuboron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Boron-containing Compounds Drug Industry Chain Analysis
7.2 Boron-containing Compounds Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Boron-containing Compounds Drug Production Mode & Process
7.4 Boron-containing Compounds Drug Sales and Marketing
7.4.1 Boron-containing Compounds Drug Sales Channels
7.4.2 Boron-containing Compounds Drug Distributors
7.5 Boron-containing Compounds Drug Customers
8 Boron-containing Compounds Drug Market Dynamics
8.1 Boron-containing Compounds Drug Industry Trends
8.2 Boron-containing Compounds Drug Market Drivers
8.3 Boron-containing Compounds Drug Market Challenges
8.4 Boron-containing Compounds Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Boron-containing Compounds Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Boron-containing Compounds Drug Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Boron-containing Compounds Drug Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Boron-containing Compounds Drug Sales (Units) of Key Manufacturers (2019-2024)
 Table 5. Global Boron-containing Compounds Drug Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Boron-containing Compounds Drug Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Boron-containing Compounds Drug Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Boron-containing Compounds Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Boron-containing Compounds Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Boron-containing Compounds Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Boron-containing Compounds Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Boron-containing Compounds Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Boron-containing Compounds Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Boron-containing Compounds Drug as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Boron-containing Compounds Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Boron-containing Compounds Drug Sales by Region (2019-2024) & (Units)
 Table 18. Global Boron-containing Compounds Drug Sales Market Share by Region (2019-2024)
 Table 19. Global Boron-containing Compounds Drug Sales by Region (2025-2030) & (Units)
 Table 20. Global Boron-containing Compounds Drug Sales Market Share by Region (2025-2030)
 Table 21. Global Boron-containing Compounds Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Boron-containing Compounds Drug Revenue Market Share by Region (2019-2024)
 Table 23. Global Boron-containing Compounds Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Boron-containing Compounds Drug Revenue Market Share by Region (2025-2030)
 Table 25. North America Boron-containing Compounds Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
 Table 27. North America Boron-containing Compounds Drug Sales by Country (2025-2030) & (Units)
 Table 28. North America Boron-containing Compounds Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Boron-containing Compounds Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Boron-containing Compounds Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
 Table 32. Europe Boron-containing Compounds Drug Sales by Country (2025-2030) & (Units)
 Table 33. Europe Boron-containing Compounds Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Boron-containing Compounds Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Boron-containing Compounds Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Boron-containing Compounds Drug Sales by Region (2019-2024) & (Units)
 Table 37. Asia Pacific Boron-containing Compounds Drug Sales by Region (2025-2030) & (Units)
 Table 38. Asia Pacific Boron-containing Compounds Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Boron-containing Compounds Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Boron-containing Compounds Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
 Table 42. Latin America Boron-containing Compounds Drug Sales by Country (2025-2030) & (Units)
 Table 43. Latin America Boron-containing Compounds Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Boron-containing Compounds Drug Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Boron-containing Compounds Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
 Table 47. Middle East and Africa Boron-containing Compounds Drug Sales by Country (2025-2030) & (Units)
 Table 48. Middle East and Africa Boron-containing Compounds Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Boron-containing Compounds Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Boron-containing Compounds Drug Sales (Units) by Type (2019-2024)
 Table 51. Global Boron-containing Compounds Drug Sales (Units) by Type (2025-2030)
 Table 52. Global Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
 Table 53. Global Boron-containing Compounds Drug Sales Market Share by Type (2025-2030)
 Table 54. Global Boron-containing Compounds Drug Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Boron-containing Compounds Drug Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Boron-containing Compounds Drug Revenue Market Share by Type (2019-2024)
 Table 57. Global Boron-containing Compounds Drug Revenue Market Share by Type (2025-2030)
 Table 58. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Boron-containing Compounds Drug Sales (Units) by Application (2019-2024)
 Table 61. Global Boron-containing Compounds Drug Sales (Units) by Application (2025-2030)
 Table 62. Global Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
 Table 63. Global Boron-containing Compounds Drug Sales Market Share by Application (2025-2030)
 Table 64. Global Boron-containing Compounds Drug Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Boron-containing Compounds Drug Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Boron-containing Compounds Drug Revenue Market Share by Application (2019-2024)
 Table 67. Global Boron-containing Compounds Drug Revenue Market Share by Application (2025-2030)
 Table 68. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2025-2030)
 Table 70. Takeda Pharmaceutical Company Information
 Table 71. Takeda Pharmaceutical Description and Business Overview
 Table 72. Takeda Pharmaceutical Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Takeda Pharmaceutical Boron-containing Compounds Drug Product
 Table 74. Takeda Pharmaceutical Recent Developments/Updates
 Table 75. Janssen Pharmaceuticals Company Information
 Table 76. Janssen Pharmaceuticals Description and Business Overview
 Table 77. Janssen Pharmaceuticals Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Janssen Pharmaceuticals Boron-containing Compounds Drug Product
 Table 79. Janssen Pharmaceuticals Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Pfizer Boron-containing Compounds Drug Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Hovione FarmaCiencia Company Information
 Table 86. Hovione FarmaCiencia Description and Business Overview
 Table 87. Hovione FarmaCiencia Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Hovione FarmaCiencia Boron-containing Compounds Drug Product
 Table 89. Hovione FarmaCiencia Recent Developments/Updates
 Table 90. Melinta Therapeutics Company Information
 Table 91. Melinta Therapeutics Description and Business Overview
 Table 92. Melinta Therapeutics Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Melinta Therapeutics Boron-containing Compounds Drug Product
 Table 94. Melinta Therapeutics Recent Developments/Updates
 Table 95. DC PHARMA Company Information
 Table 96. DC PHARMA Description and Business Overview
 Table 97. DC PHARMA Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. DC PHARMA Boron-containing Compounds Drug Product
 Table 99. DC PHARMA Recent Developments/Updates
 Table 100. Gao Jin Biology Company Information
 Table 101. Gao Jin Biology Description and Business Overview
 Table 102. Gao Jin Biology Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Gao Jin Biology Boron-containing Compounds Drug Product
 Table 104. Gao Jin Biology Recent Developments/Updates
 Table 105. Neuboron Company Information
 Table 106. Neuboron Description and Business Overview
 Table 107. Neuboron Boron-containing Compounds Drug Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Neuboron Boron-containing Compounds Drug Product
 Table 109. Neuboron Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Boron-containing Compounds Drug Distributors List
 Table 113. Boron-containing Compounds Drug Customers List
 Table 114. Boron-containing Compounds Drug Market Trends
 Table 115. Boron-containing Compounds Drug Market Drivers
 Table 116. Boron-containing Compounds Drug Market Challenges
 Table 117. Boron-containing Compounds Drug Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Boron-containing Compounds Drug
 Figure 2. Global Boron-containing Compounds Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Boron-containing Compounds Drug Market Share by Type: 2023 & 2030
 Figure 4. Bortezomib Product Picture
 Figure 5. Tavaborole Product Picture
 Figure 6. Crisaborole Product Picture
 Figure 7. Vaborbactam-Meropenem Product Picture
 Figure 8. Ixazomib Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Boron-containing Compounds Drug Market Value by Application (2024-2030) & (US$ Million)
 Figure 11. Global Boron-containing Compounds Drug Market Share by Application: 2023 & 2030
 Figure 12. Multiple Myeloma
 Figure 13. Toenail Fungal Infection
 Figure 14. Atopic Dermatitis
 Figure 15. Others
 Figure 16. Global Boron-containing Compounds Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Boron-containing Compounds Drug Market Size (2019-2030) & (US$ Million)
 Figure 18. Global Boron-containing Compounds Drug Sales (2019-2030) & (Units)
 Figure 19. Global Boron-containing Compounds Drug Average Price (US$/Unit) & (2019-2030)
 Figure 20. Boron-containing Compounds Drug Report Years Considered
 Figure 21. Boron-containing Compounds Drug Sales Share by Manufacturers in 2023
 Figure 22. Global Boron-containing Compounds Drug Revenue Share by Manufacturers in 2023
 Figure 23. Global 5 and 10 Largest Boron-containing Compounds Drug Players: Market Share by Revenue in Boron-containing Compounds Drug in 2023
 Figure 24. Boron-containing Compounds Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 25. Global Boron-containing Compounds Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 26. North America Boron-containing Compounds Drug Sales Market Share by Country (2019-2030)
 Figure 27. North America Boron-containing Compounds Drug Revenue Market Share by Country (2019-2030)
 Figure 28. United States Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Canada Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Europe Boron-containing Compounds Drug Sales Market Share by Country (2019-2030)
 Figure 31. Europe Boron-containing Compounds Drug Revenue Market Share by Country (2019-2030)
 Figure 32. Germany Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. France Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. U.K. Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Italy Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Russia Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Asia Pacific Boron-containing Compounds Drug Sales Market Share by Region (2019-2030)
 Figure 38. Asia Pacific Boron-containing Compounds Drug Revenue Market Share by Region (2019-2030)
 Figure 39. China Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Japan Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. South Korea Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. India Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Australia Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. China Taiwan Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Southeast Asia Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Latin America Boron-containing Compounds Drug Sales Market Share by Country (2019-2030)
 Figure 47. Mexico Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Brazil Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Argentina Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Colombia Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Middle East and Africa Boron-containing Compounds Drug Sales Market Share by Country (2019-2030)
 Figure 52. Middle East and Africa Boron-containing Compounds Drug Revenue Market Share by Country (2019-2030)
 Figure 53. Turkey Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Saudi Arabia Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. UAE Boron-containing Compounds Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. Global Sales Market Share of Boron-containing Compounds Drug by Type (2019-2030)
 Figure 57. Global Revenue Market Share of Boron-containing Compounds Drug by Type (2019-2030)
 Figure 58. Global Boron-containing Compounds Drug Price (US$/Unit) by Type (2019-2030)
 Figure 59. Global Sales Market Share of Boron-containing Compounds Drug by Application (2019-2030)
 Figure 60. Global Revenue Market Share of Boron-containing Compounds Drug by Application (2019-2030)
 Figure 61. Global Boron-containing Compounds Drug Price (US$/Unit) by Application (2019-2030)
 Figure 62. Boron-containing Compounds Drug Value Chain
 Figure 63. Boron-containing Compounds Drug Production Process
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart